Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

  1. López-Gálvez, R.
  2. Rivera-Caravaca, J.M.
  3. Anguita Sánchez, M.
  4. Sanmartín Fernández, M.
  5. Rafols, C.
  6. Pérez-Cabeza, A.I.
  7. Barón Esquivias, G.
  8. Lekuona Goya, I.
  9. Vázquez Rodríguez, J.M.
  10. Cosín Sales, J.
  11. Arribas Ynsaurriaga, F.
  12. Barrios, V.
  13. Freixa-Pamias, R.
  14. Marín, F.
Journal:
European Journal of Clinical Investigation

ISSN: 1365-2362 0014-2972

Year of publication: 2022

Volume: 52

Issue: 9

Type: Letter

DOI: 10.1111/ECI.13788 GOOGLE SCHOLAR

Sustainable development goals